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Abstract
Alzheimer’s disease (AD) patients display hippocampal atrophy, memory impairment, and 
cognitive decline. New neurons are generated throughout adulthood in two regions of the brain 
implicated in AD, the dentate gyrus of the hippocampus and the sub-ventricular zone of the 
olfactory bulb. Disruption of this process contributes to neurodegenerative diseases including AD 
and many of the molecular players in AD are also modulators of adult neurogenesis. However, the 
genetic mechanisms underlying adult neurogenesis in AD have been underexplored. To address 
this gap, we performed a gene-based association analysis in cognitively normal and impaired 
participants using neurogenesis pathway-related candidate genes curated from existing databases, 
literature mining, and large-scale genome-wide association study findings. A gene-based 
association analysis identified ADORA2A as significantly associated with hippocampal volume 
and the association between rs9608282 within ADORA2A and hippocampal volume was 
replicated in the meta-analysis after multiple comparison adjustments (p=7.88×10−6). The minor 
allele of rs9608282 in ADORA2A is associated with larger hippocampal volumes and better 
memory.
Keywords
Neurogenesis; ADORA2A; hippocampal volume; memory; Alzheimer’s Disease; gene-based 
association analysis; NMDA-receptor antagonist
1. Introduction
Adult neurogenesis occurs throughout life in specific regions of the brain in humans. In 
rodents, neural stem cells differentiate to new neurons in several regions of the brain, but 
studies show that adult neurogenesis is limited to the dentate gyrus (DG) of the hippocampus 
and the sub-ventricular zone of the olfactory bulb in humans (Eriksson, Perfilieva et al. 
1998, Spalding, Bergmann et al. 2013, Bond, Ming et al. 2015). The hippocampus is the 
most important region of the brain for new learning and episodic/spatial memory. The new 
neurons generated during adult neurogenesis are incorporated into hippocampal network 
circuitry during construction and maintenance of neural circuits and contribute to learning 
and memory (Aimone, Li et al. 2014, Winner and Winkler 2015). The progenitor cells in DG 
divide periodically, and DG experiences stability in neurogenesis throughout life (Scharfman 
and Bernstein 2015, Horgusluoglu, Nudelman et al. 2016). In rodents, neural stem cells 
(NSCs) in the DG make approximately 8,000 to 10,000 new neurons per day. However, the 
proportion of hippocampal neurogenesis decline in human is smaller than mice with aging 
(Amrein, Isler et al. 2011, Spalding, Bergmann et al. 2013). In 1998, the presence of adult-
born neurons in the dentate gyrus of the human hippocampus had been identified by using 
cancer patients who had received the labelled 5-bromo-2'-deoxyuridine (BrdU) in 
hippocampal neurons (Eriksson, Perfilieva et al. 1998). In adults, the annual turnover of stem 
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cells into neurons is 1.75% with a modest decline during aging (Spalding, Bergmann et al. 
2013). By contrast, the estimated annualized hippocampal atrophy rate is 1.41% per year for 
cognitively normal older people and 4.66% for patients with AD pathology (Barnes, Bartlett 
et al. 2009). Disruption of adult neurogenesis process has been postulated to contribute to 
neurodegenerative diseases including AD. Alterations in hippocampal neurogenesis in AD 
could either provide protection by proliferation of neural progenitor cells or cause 
accelerated neural degeneration due to impairment of neuronal networks and synaptic 
plasticity. Several studies in mice have combined structural MRI and histological approaches 
to investigate newborn neurons and neural stem/progenitor cells in neurogenesis-related 
brain regions and found that neurogenesis was associated with increased gray matter volume 
(Biedermann, Fuss et al. 2016). The relationship between hippocampal volume and adult 
neurogenesis in the human brain has not been studied yet.
Many molecular mechanisms and pathways play a role in the hippocampal neurogenesis 
process, including the proliferation of neural progenitor cells, the differentiation, migration, 
and maturation of adult neurons (Urban and Guillemot 2014, Horgusluoglu, Nudelman et al. 
2016). Known modulators of adult neurogenesis include signaling transduction, vascular and 
immune systems, metabolic factors, and epigenetic regulation (Urban and Guillemot 2014, 
Borsini, Zunszain et al. 2015, Horgusluoglu, Nudelman et al. 2016). In particular, multiple 
factors such as neurotrophic factors, transcription factors, and cell cycle regulators control 
NSC proliferation, maintenance in neurogenic niche, and differentiation into mature 
neurons; these factors play role in networks of signaling molecules that influence each other 
during construction of neural circuits, and contribute to learning and memory (Fig. 1).
Disruption of the neurogenesis process has been postulated to contribute to 
neurodegenerative diseases including AD (Marlatt and Lucassen 2010). However, the 
mechanisms by which AD pathology affects neurogenesis are not completely understood. 
Alterations in the early stages of AD, such as amyloid-β deposition and inflammation, may 
impair the maturation of newborn neurons and inhibit hippocampal neurogenesis (Mu and 
Gage 2011). Genetic changes in neurogenesis-related pathways and genes may also play 
important roles in the alteration of NSCs maturation into newborn neurons (Horgusluoglu, 
Nudelman et al. 2016). Pathway- or gene-based association analysis has been used to study a 
number of complex neurodegenerative diseases, including AD, using a wide variety of 
phenotypes, including cerebrospinal fluid Aβ1–42 peptide level (Han, Schellenberg et al. 
2010, Kim, Swaminathan et al. 2011), cerebral amyloid deposition (Swaminathan, Shen et 
al. 2012), brain glutamate levels (Baranzini, Srinivasan et al. 2010), and episodic memory 
(Ramanan, Kim et al. 2012). However, no study to date has evaluated the association 
between candidate neurogenesis-related genes and hippocampal volume. Thus, the goal of 
the present study was to perform a gene-based association analysis of neurogenesis pathway-
related candidate genes in cognitively normal and impaired participants from ADNI cohort. 
Identification of genes that play a role in both hippocampal neurogenesis and AD may hold 
great promise for better understanding the role of neurogenesis in AD, as well as to aid in 
discovery of novel therapeutic targets for AD.
We used well-characterized participants from extensively studied cohort Alzheimer’s 
Diasease Neuroimaging Initiatives (ADNI), which uniquely have GWAS data sets on the 
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same participants as well as multi-modal structural and functional neuroimaging (MRI, 
PET) data. A quantitative phenotype approach to genetic association studies provides the 
advantage of increased power sizes to detect significant genetic effects as compared to a 
traditional case-control design. We used hippocampal volume as a quantitative phenotype 
measured by MRI imaging, metabolic activity and amyloidosis in the hippocampus 
measured by PET imaging, and composite memory scores as quantitative traits to investigate 
that adult hippocampal neurogenesis-related genes and pathways are significantly associated 
with AD-related endophenotypes.
2. Materials and Methods
2.1. Participants
We used the participants of the Alzheimer's Disease Neuroimaging Initiative Phase 1 
(ADNI-1) and its subsequent extensions (ADNI-GO/2) for this study. ADNI was launched in 
2004 by the National Institute on Aging, the National Institute of Biomedical Imaging and 
Bioengineering, the Food and Drug Administration (FDA), private pharmaceutical 
companies, and nonprofit organizations as a public-private partnership. The aim of ADNI 
has been to identify whether serial MRI, positron emission tomography (PET), sensitive and 
specific other markers, and clinical and neuropsychological assessments could be combined 
to measure the progression of mild cognitive impairment (MCI) and early AD. Participants 
aged 55–90 in ADNI cohort include approximately 400 cognitively normal older individuals 
(CN), 100 individuals with significant memory concerns (SMC), 800 individuals diagnosed 
with MCI, and 300 individuals diagnosed with AD. Clinical and neuroimaging procedures 
and the other information about the ADNI cohort can be found at http://www.adni-info.org/.
After the initial analysis, a meta-analysis was conducted with ADNI (Nho, Corneveaux et al. 
2013, Weiner, Veitch et al. 2013) and two independent datasets, including the AddNeuroMed 
study (N=218; 66 CN, 77 MCI, 76 AD) (Lovestone, Francis et al. 2009, Nho, Corneveaux et 
al. 2013), and the Indiana Memory and Aging Study (IMAS) study (N=59; 29 CN, 24 MCI, 
6 AD) (Nho, Corneveaux et al. 2013).
Written informed consent was obtained from each participant and all protocols were 
approved by each participating study and site’s Institutional Review Board.
2.1.1. Subject selection—Only non-Hispanic Caucasian participants were selected for 
this analysis by genetic clustering with CEU (Utah residents with Northern and Western 
European ancestry from the CEPH collection) and TSI (Tuscans in Italy) populations using 
HapMap 3 genotype data and multidimensional scaling (MDS) analysis after performing 
standard quality control (QC) procedures for genetic markers and participants (Ramanan, 
Risacher et al. 2014). Overall, 1,563 non-Hispanic Caucasian participants were included, as 
their genome-wide association study (GWAS) data passed the above population stratification 
and all other standard QC procedures (Kim, Swaminathan et al. 2011). Demographic 
information is shown in Table 1 for these participants.
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2.2. Identification of candidate genes
Candidate genes which control the turnover process of neural stem cells/precursors to new 
functional neurons during adult neurogenesis were manually curated using a pathway-based 
systems biology approach (Fig. 1). Genes from known modulators of adult neurogenesis 
include those involved in signaling transduction, vascular and immune system function, 
metabolic factors, and epigenetic regulation (Nho, Corneveaux et al. 2013, Funa and 
Sasahara 2014, Urban and Guillemot 2014, Yao and Jin 2014, Borsini, Zunszain et al. 2015). 
Pathway-based approaches were used to manually curate these hippocampal neurogenesis-
related genes through a review of existing databases and literature mining, resulting in a 
final gene list (Fig. 2). Specifically, we identified hippocampal neurogenesis-related genes 
using four publicly available databases (GoGene, Qiagen RT2 Profiler PCR Arrays, Gene 
Ontology (GO) with Gene Set Enrichment Analysis (GSEA), and Mammalian Adult 
Neurogenesis Gene Ontology (MANGO)) and literature mining.
GoGene contains high-quality manual annotation with high-throughput text mining from 
literature using ontology terms. This database includes associations between genes and 
gene-related terms for ten model organisms extracted from more than 18,000,000 PubMed 
entries that cover process, function, location of genes and their relationship with diseases 
and compounds (http://gopubmed.org/gogene) (Plake, Royer et al. 2009). We performed a 
search for GoGene term “adult neurogenesis” to identify neurogenesis-related genes.
Qiagen RT2 Profiler PCR Arrays are the one of the most reliable tools to analyze the 
expression of genes related to specific pathways. The human Neurogenesis RT2 Profiler™ 
PCR Array contains 84 genes, manually curated using literature mining, which are highly 
related to the process of neurogenesis, such as neural stem/progenitor cells proliferation, 
differentiation, migration, and maturation into newborn neurons (www.qiagen.com). Growth 
factors, inflammatory cytokines, cell adhesion molecules, and cell signaling genes involved 
in the neurogenesis process were also represented in this profiling array. We included all 
genes from this Neurogenesis array in our gene list.
DAVID (the Database for Annotation, Visualization, and Integrated Discovery) is a publicly 
available functional tool which includes annotations from Gene Ontology (GO). Gene Set 
Enrichment Analysis (GSEA) pathway annotations were downloaded from Molecular 
Signatures Database version 5.0 (http://software.broadinstitute.org/gsea/msigdb). This 
annotation data comprised a collection of GO. A GO annotation contains a GO term 
associated with a specific reference which expresses the target or analysis associated with a 
specific gene product. Each GO term belongs to molecular function (Naveh, Shahar et al.), 
cellular component (CC), or biological process (BP). “Neurogenesis” was used as the GO 
term in this analysis to identify neurogenesis related gene sets from the GSEA database.
We also used MANGO, which consists of 259 genes designed and curated by Overall et al. 
(Overall, Paszkowski-Rogacz et al. 2012). In MANGO, all genes are classified by their 
positive, negative, or neutral effect on hippocampal neurogenesis and thusly annotated. We 
used recently updated MANGO version 3.1 to annotate genes.
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We identified 510 genes from GoGene, 84 genes from Neurogenesis RT2 Profiler™ PCR 
Array, 259 genes from MANGO database, and 93 genes from GSEA/Molecular Signatures 
Database. We combined all genes related to neurogenesis from the four databases (N=748). 
Then, each gene related to hippocampal neurogenesis was annotated from relevant literature. 
Initial Pubmed search using the keywords “adult hippocampal neurogenesis” for papers 
published until 9/2016 included 2,717 articles. We used Pubmed to identify if all 748 genes 
are related to hippocampal neurogenesis from 2,717 articles. After literature mining, among 
748 genes, only 401 genes were related to adult hippocampal neurogenesis.
Finally, since a key goal was to identify candidate genes playing a role in both adult 
hippocampal neurogenesis and AD pathology, we focused on hippocampal neurogenesis-
related genes which are also implicated in AD. For this purpose, we identified AD-
associated susceptibility genes using the AlzGene database (http://www.alzgene.org/), which 
provides a comprehensive meta-analysis of genes previously identified in various AD 
association studies, and large-scale AD GWAS results (N=680) (Lambert, Ibrahim-Verbaas 
et al. 2013). The AlzGene database consists of a comprehensive, unbiased, publicly available 
catalog of all genetic association studies in the field of AD, which was identified from 
published papers by pubMed search using keywords “alzheimer* AND (genet* OR 
associat*)”. The gene list in AlzGene represents a summary of promising AD candidate 
genes. We then compared this gene list to the 401 genes previously identified as involved in 
adult hippocampal neurogenesis to filter the lists to 81 common genes related to both 
hippocampal neurogenesis and AD. These 81 genes were used in the association analysis.
2.3. Endophenotypes
Pre-processed baseline 1.5T and 3T MRI scans from 1,563 participants were downloaded 
from ADNI public website (http://adni.loni.usc.edu). FreeSurfer version 5.1 was used to 
extract total hippocampal and hippocampal subfield volumes, as well as total intracranial 
volume (ICV) (Dale, Fischl et al. 1999, Fischl, Sereno et al. 1999, Risacher, Kim et al. 2013, 
Risacher, Kim et al. 2015). Total hippocampal volume, as well as selected adult 
neurogenesis-related subfield volumes (CA1, CA23, CA4, and DG) (N=1,563), were used as 
endophenotypes for the association analysis. In addition, we used a composite score of 
episodic memory (N=1,563) (Crane, Carle et al. 2012) and CSF total tau levels (N=1,112) as 
endophenotypes to further characterize neurodegeneration (Shaw, Vanderstichele et al. 2009, 
Shaw, Vanderstichele et al. 2011).
2.4. Genotyping and Quality Control
ADNI samples were genotyped using Human 610-Quad, HumanOmni Express, and 
HumanOmni 2.5M BeadChips. Sample and SNP quality control procedures of GWAS data 
such as SNP call rate < 95%, Hardy-Weinberg equilibrium test p < 1 × 10−6, and frequency 
filtering (MAF ≥ 5%) were performed (Purcell, Neale et al. 2007, Saykin, Shen et al. 2010, 
Hohman, Koran et al. 2014, Ramanan, Risacher et al. 2014). Imputation of un-genotyped 
SNPs was performed using MaCH (Markov Chain Haplotyping) software based on the 1000 
Genomes Project as a reference panel (Howie, Fuchsberger et al. 2012).
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2.5. Association Analysis and Meta-Analysis
SNPs from the 81 candidate genes were located in untranslated regions (Laussu, Khuong et 
al. 2014), 3′ UTR, 5′ UTR, coding regions, intronic regions, and regulatory regions (±20 
kb of upstream and downstream regions). A gene-based association analysis of hippocampal 
neurogenesis pathway-related candidate genes was performed in an additive genetic model 
using a set-based test in Plink v1.07 (http://pngu.mgh.harvard.edu/~purcell/plink/) (Purcell, 
Neale et al. 2007). After frequency and genotyping pruning, 18407 SNPs remained from 81 
genes. (Purcell, Neale et al. 2007). After frequency and genotyping pruning, 18407 SNPs 
remained from 81 genes. A mean test statistic for each SNP within a gene was computed to 
determine other SNPs in linkage disequilibrium (LD; i.e., r2>0.5). A quantitative trait 
analysis (QT) was then performed with each SNP. For each gene (set), the top independent 
SNPs (i.e., not in LD; maximum of 5) were selected if their p-values were less than 0.05 in 
the QT analysis. The SNP with the smallest p-value was selected first; subsequent 
independent SNPs were selected in order of decreasing statistical significance. From these 
subsets of SNPs, the statistic for each set was calculated as the mean of these single SNP 
statistics. The analysis was performed to estimate the additive effect of the selected SNP 
minor allele on the phenotypic mean (Purcell, Neale et al. 2007, Swaminathan, Shen et al. 
2012). Covariates included gender, age, years of education, ICV, MRI field strength (1.5T vs 
3T) and diagnosis status. An empirical p-value (20,000 permutations) was reported for each 
gene. In the discovery sample (ADNI-1/GO/2), a conservative significance threshold (p < 
0.00061) was used based on Bonferroni correction for 81 genes. We subsequently performed 
a meta-analysis for genes and SNPs associated with hippocampal volume using data from 
the ADNI-1/GO/2, AddNeuroMed, and IMAS cohorts. The gene-based meta-analysis was 
performed using the weighted z statistic test (Stouffer’s weighted z statistic) as implemented 
in R, with weight accounting for the sample size of each cohort. For SNP-based meta-
analysis, METAL was used with a fixed-effect inverse variance model (Willer, Li et al. 
2010). For meta-analysis, effect sizes were provided by standardized β coefficients from 
linear regression.
We also evaluated the effect of the minor allele rs9608282-T on hippocampal volume and 
composite memory score after the participants, which included only those diagnosed with 
MCI or AD, were classified as either a Memantine user (NMDA (+)) or a Memantine non-
user (NMDA (−)) using two-way analysis of covariance (ANCOVA) for continuous 
variables and a chi-square for categorical variables implemented in SPSS 23.0. In addition, 
two-way analysis of covariance (ANCOVA) was used to examine the effect of the minor 
allele (rs9608282-T) on hippocampal volume in both amyloid-negative and amyloid-positive 
participants (classified as positive or negative by either baseline [18F]Florbetapir PET scans 
and/or CSF Aβ1–42 level).
3. Results
3.1. Gene-based and SNP-based analysis of mean volumes of hippocampus and 
hippocampal sub-regions
The manual gene/pathway curation for hippocampal neurogenesis yielded 18407 SNPs in 81 
genes (Fig. 2). In the discovery sample, the gene-based association analysis showed that 
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APOE and ADORA2A were significantly associated with hippocampal volume after 
Bonferroni correction (p-value=5×10−5; Table 2).
One SNP (rs9608282) upstream of ADORA2A was most significantly associated with total 
hippocampal volume and sum of the hippocampal sub-region volumes (p = 1.14×10−5 and 
2.5×10−4, respectively; Table 3). Specifically, participants with no copies of the minor allele 
(N=1,317; GG genotype) had a smaller mean hippocampal volume compared to participants 
with one copy of the minor allele (N=236; TG genotype) or participants with two copies of 
the minor allele (N=10; TT genotype).
For replication of our major significant SNP finding, we analyzed independent samples from 
the ADNI, AddNeuroMed IMAS cohorts. SNP-based meta-analysis of ADORA2A in three 
independent cohorts (ADNI1/GO/2, AddNeuroMed, and IMAS) identified that rs9608282-T 
in ADORA2A are significantly associated with hippocampal volume (p = 0.000043, 
N=1,840, Table 4; p = 7.88×10−6, N= 1,840, Table 5, respectively). In ADNI1/GO/2, 
AddNeuroMed cohorts except IMAS, rs9608282-T exhibited a positive direction of effect on 
hippocampal volume.
Following the SNP-based association analysis, we performed a post-hoc analysis to measure 
the interaction effect of APOE and the ADORA2A SNP on hippocampal volume. There was 
no evidence of epistasis, modeled as interaction between APOE ε4 status and the minor 
allele of rs9608282 (p = 0.54). However, ADORA2A rs9608282-T and APOE ε4 exhibited 
independent but opposite effects on hippocampal volume (Fig. 3A, 3B), with a comparable 
effect sizes between the APOE ε4 allele and the presence of at least one copy of the minor 
allele at rs9608282. Participants carrying at least one copy of the minor allele of the 
ADORA2A SNP have larger hippocampal volumes than those without the minor allele, even 
in participants with APOE ε4 (p=0.001; Fig. 3C). The positive effect of the ADORA2A 
rs9608282-T allele on hippocampal volume was seen in both amyloid-negative and amyloid-
positive participants (classified as positive or negative by either baseline [18F]Florbetapir 
PET scans and/or CSF Aβ1–42 level). Specifically, rs9608282-T was significantly 
associated with larger hippocampal volumes in Aβ negative (p-value = 0.027) and Aβ 
positive participants (p-value = 0.015, Fig. 4). In addition, the association of the rs9608282-
T allele with hippocampal volume and neurogenesis-related to sub-regions independent of 
diagnosis suggests that this effect might be a global phenomenon.
Since previous studies have suggested that ADORA2A plays an important role controlling 
NMDA-dependent synaptic toxicity and memory impairment (Tebano, Martire et al. 2005, 
Yee, Singer et al. 2007, Sarantis, Tsiamaki et al. 2015), we examined the interaction of 
taking Memantine, a NMDA-receptor antagonist, and ADORA2A rs9608282 on 
hippocampal volume and memory performance. Participants diagnosed with MCI or AD 
were classified as either a Memantine user (NMDA+) or a Memantine non-user (NMDA−). 
We found that NMDA-participants carrying at least one copy of the minor allele (T) of the 
ADORA2A rs9608282 had a larger mean hippocampal volume (p<0.001; Fig. 5A). There 
was a significant interaction effect of NMDA-receptor antagonist use and ADORA2A 
rs9608282 on memory performance (p = 0.009). NMDA+ participants carrying two copies 
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of the major allele (G) of the ADORA2A rs9608282 had better memory performance (Fig. 
5B).
3.2. Association of rs9608282 with episodic memory and CSF level of total tau
Given the association of ADORA2A rs9608282-T with larger hippocampal volume, we 
hypothesized that ADORA2A would also associated with episodic memory scores as they 
are highly related to hippocampal structure. As might be hypothesized, rs9608282-T was 
significantly associated with a better composite memory score (β=0.065; p=0.015) after 
controlling for age, gender, and years of education (Fig. 6).
A previous study suggested that hyperphosphorylated tau decreases adult neurogenesis in 
mouse model (Komuro, Xu et al. 2015). Therefore, we also assessed the effect of the 
rs9608282-T minor allele on CSF total tau level. As we hypothesized, rs9608282-T carriers 
showed decreased CSF total tau levels relative to non-carriers (β=−0.061; p=0.039), after 
controlling for age and gender (Fig. 7). However, there is no correlations of rs9608282 with 
CSF Aβ and phospho-tau levels.
Finally, we used gene expression data from the Allen Human Brain Atlas to evaluate if 
ADORA2A was expressed in neurogenesis-related regions in normal brains. ADORA2A 
was in fact highly expressed across the major adult neurogenesis related regions of the brain 
(Fig. 8) and was especially highly expressed in CA1 and CA2.
4. Discussion
We used well-characterized participants from the Alzheimer’s Disease Neuroimaging 
Initiatives (ADNI), an extensively studied cohort that includes cognitively normal older 
individuals (CN), as well as participants with significant memory concerns (SMC), amnestic 
mild cognitive impairment (MCI), and Alzheimer’s Disease (AD). Using targeted 
neurogenesis pathway-based gene analysis, we discovered a significant association of 
ADORA2A rs9608282-T with larger mean hippocampal volumes and volumes of 
neurogenesis-related hippocampal sub-regions, better episodic memory performance, and 
reduced CSF total tau. These findings suggested a protective effect of this SNP on brain 
structure and function in neurogenesis-related brain regions.
ADORA2A (Adenosine Receptor Subtype A2a) is a G-protein-coupled adenosine receptor 
that is involved with controlling synaptic plasticity in glutamatergic synapses (Cunha, Ferre 
et al. 2008, Krugel 2015). Previous work had indicated a physical and functional interaction 
of ADORA2A with dopamine D2 receptors (Chen, Moratalla et al. 2001). However, A1R–
A2AR heteromer controls the affinity of agonist binding to A2a receptors in the striatum and 
localizes in glutamatergic nerve terminals to control glutamate release (Ciruela, Casado et al. 
2006). In addition to its abundance in the striatum, ADORA2A also plays an important role 
in hippocampus, particularly in neurogenesis in the CA3 region. A previous study 
demonstrated that inhibition of the A2a receptor induced synaptic damage in rat 
hippocampal nerve terminals (Cunha, Canas et al. 2006).
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A reduction of A2a receptors in mice with traumatic brain injury has also been shown to 
decrease cognitive impairment (Ning, Yang et al. 2013). In fact, the adenosine 2a receptor 
localizes in microglial cells and may be a regulation of microglial function in response to 
brain damage (Cunha, Ferre et al. 2008). Since neuroinflammatory blockade is thought to 
enhance neural stem/progenitor cells activity and promote adult neurogenesis, A2a receptor-
mediated control of neuroinflammation might be a vital mechanism in neurodegenerative 
diseases (Monje, Toda et al. 2003). Inhibition of the A2a receptor also prevents early Aβ-
induced synaptotoxicity and memory dysfunction through a p38 MAPK-dependent pathway 
(Canas, Porciuncula et al. 2009), potentially suggesting additional roles for this receptor in 
AD. In fact, ADORA2A blockade prevented memory decline secondary to amyloid-beta 
accumulation, which is a major pathological hallmark in AD (Cunha, Canas et al. 2008). 
Another important role of ADORA2A is to modulate brain-derived neurotrophic factor 
(BDNF). Administration of an ADORA2A antagonist inhibits the actions of BDNF on 
GABA and glutamate release from the hippocampal nerve terminals (Vaz, Lerias et al. 
2015). In addition, the A2a receptor is involved with control of N-methyl-D-aspartate 
(NMDA) receptor function by co-localizing with metabotropic glutamate 5 receptors 
(Glu5R) in hippocampal synapses (Tebano, Martire et al. 2005). The synaptic localization of 
A2a receptors plays a key role controlling NMDA-dependent synaptic transmission in the 
hippocampus (Rebola, Sachidhanandam et al. 2007). In fact, glutamate release is dependent 
on the activation of adenosine A2AR by endogenous adenosine (Canas, Porciuncula et al. 
2009, Vaz, Lerias et al. 2015). Previous studies showed the relationship between NMDA 
receptor and Adenosine Receptor Subtype A2a, which supports our finding of a significant 
interaction effect of NMDA-receptor antagonist use and the ADORA2A rs9608282-T on 
memory performance.
rs9608282 is located upstream of ADORA2A (UCSC Genome Browser (GRCh37/hg19)) 
and is characterized by occurring during read-through transcription of two neighbor genes, 
SPECC1L (sperm antigen with calponin homology and coiled-coil domains 1-like) and 
ADORA2A (adenosine A2a receptor) on chromosome 22. This read-through transcription is 
a candidate for nonsense-mediated mRNA decay (NMD), which leads to no protein 
production. The inhibition of ADORA2A has been shown to enhance spatial memory and 
hippocampal plasticity through adult neurogenesis (Laurent, Burnouf et al. 2016). In the 
present study, rs9608282-T was associated with better memory and a larger hippocampal 
volume, suggesting that this variation may inhibit protein production of ADORA2A. Animal 
models or cell culture studies are needed to more completely characterize the function of 
this variation on brain structure and adult neurogenesis.
Based on gene expression data from postmortem human brains, the A2A receptor is highly 
expressed in neurogenesis-related regions (CA1, CA2, CA3 and dentate gyrus) of the 
hippocampus in the adult human brain. Since the dentate gyrus and CA3 regions are 
important for memory formation and pattern separation processes, as well as for learning 
new information, we believe the observed effect of the rs9608282-T variation may be 
protective for memory performance by altering neurogenesis in these regions. In addition, 
the association of the rs9608282-T allele with hippocampal volume and neurogenesis-related 
sub-regions independent of diagnosis suggests that this effect might be a global rather than 
AD-specific phenomenon. Consistent with protective effect of this variant, decreased CSF 
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total-tau protein levels were also observed in participants with at least one minor allele (T) 
of rs9608282.
Interestingly, ADORA2A rs9608282-T and APOE ε4 exhibit an independent but opposite 
effect on hippocampal volume. In sum, we observed a significant protective effect of a 
variant (rs9608282) in the neurogenesis-related ADORA2A gene on brain structure and 
function, including increased hippocampal volume, better memory performance, and 
reduced CSF tau. This finding suggests that the adenosine A2a receptor warrants further 
investigation as a potential target for future therapeutics to treat neurodegenerative disease 
and cognitive decline.
The eQTL analysis using the BRAINEAC brain tissue microarray-based gene expression 
database (http://www.braineac.org/) revealed that rs9608282 in ADORA2A is marginally 
associated with ADORA2A gene expression levels in the hippocampus (p-value = 0.172). 
Individuals carrying minor allele rs9608282-T have decreased expression levels in the 
hippocampus, showing a potential protective effect consistent with our SNP-based 
association results with hippocampal volume and memory. Increased ADORA2A levels lead 
to synaptic toxicity and memory impairment (Tebano, Martire et al. 2005, Yee, Singer et al. 
2007, Sarantis, Tsiamaki et al. 2015).
The limitation of the present report is that even though we used three independent publicly 
available databases to identify a curated gene list related to adult neurogenesis, it is possible 
that we may have missed other neurogenesis related genes not represented in these 
databases. The other limitation is that even though a few studies combined MRI-based 
hippocampal volume with immunochemistry to reveal that there is a significant hippocampal 
atrophy and the reduction of hippocampal neurogenesis in animal models, it is still not clear 
if hippocampal atrophy is related to adult neurogenesis in humans due to lack of data 
sources. Another limitation for this study is the lack of replication in the gene-based 
analysis. In the AddNeuroMed and IMAS, ADORA2A did not show a significant 
association with hippocampal volume but showed a trend. After combining three 
independent cohorts, the meta-analysis result was significant due to the increased detection 
power. In addition, future studies are needed to identify functional evidence to validate this 
SNP in ADORA2A. However, the present findings support that the ADORA2A gene plays a 
role in adult neurogenesis. AD is associated with hippocampal volume loss the observed 
effects indicates the potential importance of further investigation of this gene in independent 
cohorts.
Acknowledgments
Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) 
(National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number 
W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical 
Imaging and Bioengineering, and through generous contributions from the following: Alzheimer’s Association; 
Alzheimer’s Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai 
Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company 
Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & 
Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & 
Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; 
Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health 
Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by 
Horgusluoglu-Moloch et al. Page 11
Neurobiol Aging. Author manuscript; available in PMC 2018 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern 
California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease 
Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for 
Neuro Imaging at the University of Southern California. Samples from the National Cell Repository for AD 
(NCRAD), which receives government support under a cooperative agreement grant (U24 AG21886) awarded by 
the National Institute on Aging (AIG), were used in this study. Funding for the WGS was provided by the 
Alzheimer’s Association and the Brin Wojcicki Foundation.
Additional support for data analysis was provided by NLM R01 LM012535, NIA R03 AG054936, NIA R01 
AG19771, NIA P30 AG10133, NLM R01 LM011360, NSF IIS-1117335, DOD W81XWH-14-2-0151, NCAA 
14132004, NIGMS P50GM115318, NCATS UL1 TR001108, NIA K01 AG049050, the Alzheimer’s Association, 
the Indiana Clinical and Translational Science Institute, and the IU Health-IU School of Medicine Strategic 
Neuroscience Research Initiative.
References
Aimone JB, Li Y, Lee SW, Clemenson GD, Deng W, Gage FH. Regulation and function of adult 
neurogenesis: from genes to cognition. Physiol Rev. 2014; 94(4):991–1026. [PubMed: 25287858] 
Amrein I, Isler K, Lipp HP. Comparing adult hippocampal neurogenesis in mammalian species and 
orders: influence of chronological age and life history stage. Eur J Neurosci. 2011; 34(6):978–987. 
[PubMed: 21929629] 
Baranzini SE, Srinivasan R, Khankhanian P, Okuda DT, Nelson SJ, Matthews PM, Hauser SL, 
Oksenberg JR, Pelletier D. Genetic variation influences glutamate concentrations in brains of 
patients with multiple sclerosis. Brain. 2010; 133(9):2603–2611. [PubMed: 20802204] 
Barnes J, Bartlett JW, van de Pol LA, Loy CT, Scahill RI, Frost C, Thompson P, Fox NC. A meta-
analysis of hippocampal atrophy rates in Alzheimer's disease. Neurobiol Aging. 2009; 30(11):1711–
1723. [PubMed: 18346820] 
Biedermann SV, Fuss J, Steinle J, Auer MK, Dormann C, Falfan-Melgoza C, Ende G, Gass P, Weber-
Fahr W. The hippocampus and exercise: histological correlates of MR-detected volume changes. 
Brain Struct Funct. 2016; 221(3):1353–1363. [PubMed: 25550000] 
Bond AM, Ming GL, Song H. Adult Mammalian Neural Stem Cells and Neurogenesis: Five Decades 
Later. Cell Stem Cell. 2015; 17(4):385–395. [PubMed: 26431181] 
Borsini A, Zunszain PA, Thuret S, Pariante CM. The role of inflammatory cytokines as key modulators 
of neurogenesis. Trends Neurosci. 2015; 38(3):145–157. [PubMed: 25579391] 
Canas PM, Porciuncula LO, Cunha GM, Silva CG, Machado NJ, Oliveira JM, Oliveira CR, Cunha RA. 
Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by 
beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J Neurosci. 2009; 29(47):
14741–14751. [PubMed: 19940169] 
Chen JF, Moratalla R, Impagnatiello F, Grandy DK, Cuellar B, Rubinstein M, Beilstein MA, Hackett 
E, Fink JS, Low MJ, Ongini E, Schwarzschild MA. The role of the D(2) dopamine receptor (D(2)R) 
in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by 
A(2A) and D(2) receptor knockout mice. Proc Natl Acad Sci U S A. 2001; 98(4):1970–1975. 
[PubMed: 11172060] 
Ciruela F, Casado V, Rodrigues RJ, Lujan R, Burgueno J, Canals M, Borycz J, Rebola N, Goldberg 
SR, Mallol J, Cortes A, Canela EI, Lopez-Gimenez JF, Milligan G, Lluis C, Cunha RA, Ferre S, 
Franco R. Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A 
receptor heteromers. J Neurosci. 2006; 26(7):2080–2087. [PubMed: 16481441] 
Crane PK, Carle A, Gibbons LE, Insel P, Mackin RS, Gross A, Jones RN, Mukherjee S, Curtis SM, 
Harvey D, Weiner M, Mungas D, I. Alzheimer's Disease Neuroimaging. Development and 
assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative 
(ADNI). Brain Imaging Behav. 2012; 6(4):502–516. [PubMed: 22782295] 
Cunha GM, Canas PM, Melo CS, Hockemeyer J, Muller CE, Oliveira CR, Cunha RA. Adenosine A2A 
receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by 
scopolamine or MK-801. Exp Neurol. 2008; 210(2):776–781. [PubMed: 18191838] 
Cunha GM, Canas PM, Oliveira CR, Cunha RA. Increased density and synapto-protective effect of 
adenosine A2A receptors upon sub-chronic restraint stress. Neuroscience. 2006; 141(4):1775–
1781. [PubMed: 16797134] 
Horgusluoglu-Moloch et al. Page 12
Neurobiol Aging. Author manuscript; available in PMC 2018 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Cunha RA, Ferre S, Vaugeois JM, Chen JF. Potential therapeutic interest of adenosine A2A receptors 
in psychiatric disorders. Curr Pharm Des. 2008; 14(15):1512–1524. [PubMed: 18537674] 
Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface 
reconstruction. Neuroimage. 1999; 9(2):179–194. [PubMed: 9931268] 
Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH. 
Neurogenesis in the adult human hippocampus. Nat Med. 1998; 4(11):1313–1317. [PubMed: 
9809557] 
Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II: Inflation, flattening, and a surface-
based coordinate system. Neuroimage. 1999; 9(2):195–207. [PubMed: 9931269] 
Funa K, Sasahara M. The roles of PDGF in development and during neurogenesis in the normal and 
diseased nervous system. J Neuroimmune Pharmacol. 2014; 9(2):168–181. [PubMed: 23771592] 
Han MR, Schellenberg GD, Wang LS, I. Alzheimer's Disease Neuroimaging. Genome-wide 
association reveals genetic effects on human Abeta42 and tau protein levels in cerebrospinal fluids: 
a case control study. BMC Neurol. 2010; 10:90. [PubMed: 20932310] 
Hohman TJ, Koran ME, Thornton-Wells TA, I. Alzheimer's Neuroimaging. Genetic variation modifies 
risk for neurodegeneration based on biomarker status. Front Aging Neurosci. 2014; 6:183. 
[PubMed: 25140149] 
Horgusluoglu E, Nudelman K, Nho K, Saykin AJ. Adult neurogenesis and neurodegenerative diseases: 
A systems biology perspective. Am J Med Genet B Neuropsychiatr Genet. 2016
Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype 
imputation in genome-wide association studies through pre-phasing. Nat Genet. 2012; 44(8):955–
959. [PubMed: 22820512] 
Kim S, Swaminathan S, Shen L, Risacher SL, Nho K, Foroud T, Shaw LM, Trojanowski JQ, Potkin 
SG, Huentelman MJ, Craig DW, DeChairo BM, Aisen PS, Petersen RC, Weiner MW, Saykin AJ, I. 
Alzheimer's Disease Neuroimaging. Genome-wide association study of CSF biomarkers Abeta1–
42, t-tau, and p-tau181p in the ADNI cohort. Neurology. 2011; 76(1):69–79. [PubMed: 21123754] 
Komuro Y, Xu G, Bhaskar K, Lamb BT. Human tau expression reduces adult neurogenesis in a mouse 
model of tauopathy. Neurobiol Aging. 2015; 36(6):2034–2042. [PubMed: 25863528] 
Krugel U. Purinergic receptors in psychiatric disorders. Neuropharmacology. 2015
Laurent C, Burnouf S, Ferry B, Batalha VL, Coelho JE, Baqi Y, Malik E, Mariciniak E, Parrot S, Van 
der Jeugd A, Faivre E, Flaten V, Ledent C, D'Hooge R, Sergeant N, Hamdane M, Humez S, Muller 
CE, Lopes LV, Buee L, Blum D. A2A adenosine receptor deletion is protective in a mouse model 
of Tauopathy. Mol Psychiatry. 2016; 21(1):149. [PubMed: 26216297] 
Laussu J, Khuong A, Gautrais J, Davy A. Beyond boundaries--Eph:ephrin signaling in neurogenesis. 
Cell Adh Migr. 2014; 8(4):349–359. [PubMed: 25482631] 
Lovestone S, Francis P, Kloszewska I, Mecocci P, Simmons A, Soininen H, Spenger C, Tsolaki M, 
Vellas B, Wahlund LO, Ward M, C. AddNeuroMed. AddNeuroMed--the European collaboration 
for the discovery of novel biomarkers for Alzheimer's disease. Ann N Y Acad Sci. 2009; 1180:36–
46. [PubMed: 19906259] 
Marlatt MW, Lucassen PJ. Neurogenesis and Alzheimer's disease: Biology and pathophysiology in 
mice and men. Curr Alzheimer Res. 2010; 7(2):113–125. [PubMed: 19860727] 
Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. 
Science. 2003; 302(5651):1760–1765. [PubMed: 14615545] 
Mu Y, Gage FH. Adult hippocampal neurogenesis and its role in Alzheimer's disease. Mol 
Neurodegener. 2011; 6:85. [PubMed: 22192775] 
Naveh GR, Shahar R, Brumfeld V, Weiner S. Tooth movements are guided by specific contact areas 
between the tooth root and the jaw bone: A dynamic 3D microCT study of the rat molar. J Struct 
Biol. 2012; 177(2):477–483. [PubMed: 22138090] 
Nho K, Corneveaux JJ, Kim S, Lin H, Risacher SL, Shen L, Swaminathan S, Ramanan VK, Liu Y, 
Foroud T, Inlow MH, Siniard AL, Reiman RA, Aisen PS, Petersen RC, Green RC, Jack CR, 
Weiner MW, Baldwin CT, Lunetta K, Farrer LA, S. Multi-Institutional Research on Alzheimer 
Genetic Epidemiology; Furney SJ, Lovestone S, Simmons A, Mecocci P, Vellas B, Tsolaki M, 
Kloszewska I, Soininen H, C. AddNeuroMed; McDonald BC, Farlow MR, Ghetti B, Indiana M, 
Aging S, Huentelman MJ, Saykin AJ, I. Alzheimer's Disease Neuroimaging. Whole-exome 
Horgusluoglu-Moloch et al. Page 13
Neurobiol Aging. Author manuscript; available in PMC 2018 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
sequencing and imaging genetics identify functional variants for rate of change in hippocampal 
volume in mild cognitive impairment. Mol Psychiatry. 2013; 18(7):781–787. [PubMed: 23608917] 
Ning YL, Yang N, Chen X, Xiong RP, Zhang XZ, Li P, Zhao Y, Chen XY, Liu P, Peng Y, Wang ZG, 
Chen JF, Zhou YG. Adenosine A2A receptor deficiency alleviates blast-induced cognitive 
dysfunction. J Cereb Blood Flow Metab. 2013; 33(11):1789–1798. [PubMed: 23921902] 
Overall RW, Paszkowski-Rogacz M, Kempermann G. The mammalian adult neurogenesis gene 
ontology (MANGO) provides a structural framework for published information on genes 
regulating adult hippocampal neurogenesis. PLoS One. 2012; 7(11):e48527. [PubMed: 23139788] 
Plake C, Royer L, Winnenburg R, Hakenberg J, Schroeder M. GoGene: gene annotation in the fast 
lane. Nucleic Acids Res. 2009; 37(Web Server issue):W300–304. [PubMed: 19465383] 
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker 
PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based 
linkage analyses. Am J Hum Genet. 2007; 81(3):559–575. [PubMed: 17701901] 
Ramanan VK, Kim S, Holohan K, Shen L, Nho K, Risacher SL, Foroud TM, Mukherjee S, Crane PK, 
Aisen PS, Petersen RC, Weiner MW, Saykin AJ, I. Alzheimer's Disease Neuroimaging. Genome-
wide pathway analysis of memory impairment in the Alzheimer's Disease Neuroimaging Initiative 
(ADNI) cohort implicates gene candidates, canonical pathways, and networks. Brain Imaging 
Behav. 2012; 6(4):634–648. [PubMed: 22865056] 
Ramanan VK, Risacher SL, Nho K, Kim S, Swaminathan S, Shen L, Foroud TM, Hakonarson H, 
Huentelman MJ, Aisen PS, Petersen RC, Green RC, Jack CR, Koeppe RA, Jagust WJ, Weiner 
MW, Saykin AJ, I. Alzheimer's Disease Neuroimaging. APOE and BCHE as modulators of 
cerebral amyloid deposition: a florbetapir PET genome-wide association study. Mol Psychiatry. 
2014; 19(3):351–357. [PubMed: 23419831] 
Rebola N, Sachidhanandam S, Perrais D, Cunha RA, Mulle C. Short-term plasticity of kainate 
receptor-mediated EPSCs induced by NMDA receptors at hippocampal mossy fiber synapses. J 
Neurosci. 2007; 27(15):3987–3993. [PubMed: 17428973] 
Risacher SL, Kim S, Nho K, Foroud T, Shen L, Petersen RC, Jack CR Jr, Beckett LA, Aisen PS, 
Koeppe RA, Jagust WJ, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ, I. Alzheimer's 
Disease Neuroimaging. APOE effect on Alzheimer's disease biomarkers in older adults with 
significant memory concern. Alzheimers Dement. 2015; 11(12):1417–1429. [PubMed: 25960448] 
Risacher SL, Kim S, Shen L, Nho K, Foroud T, Green RC, Petersen RC, Jack CR Jr, Aisen PS, Koeppe 
RA, Jagust WJ, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ, d. Alzheimer's Disease 
Neuroimaging Initiative. The role of apolipoprotein E (APOE) genotype in early mild cognitive 
impairment (E-MCI). Front Aging Neurosci. 2013; 5:11. [PubMed: 23554593] 
Sarantis K, Tsiamaki E, Kouvaros S, Papatheodoropoulos C, Angelatou F. Adenosine A(2)A receptors 
permit mGluR5-evoked tyrosine phosphorylation of NR2B (Tyr1472) in rat hippocampus: a 
possible key mechanism in NMDA receptor modulation. J Neurochem. 2015; 135(4):714–726. 
[PubMed: 26303340] 
Saykin AJ, Shen L, Foroud TM, Potkin SG, Swaminathan S, Kim S, Risacher SL, Nho K, Huentelman 
MJ, Craig DW, Thompson PM, Stein JL, Moore JH, Farrer LA, Green RC, Bertram L, Jack CR Jr, 
Weiner MW, I. Alzheimer's Disease Neuroimaging. Alzheimer's Disease Neuroimaging Initiative 
biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers 
Dement. 2010; 6(3):265–273. [PubMed: 20451875] 
Scharfman HE, Bernstein HL. Potential implications of a monosynaptic pathway from mossy cells to 
adult-born granule cells of the dentate gyrus. Front Syst Neurosci. 2015; 9:112. [PubMed: 
26347618] 
Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, 
Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ, I. 
Alzheimer's Disease Neuroimaging. Cerebrospinal fluid biomarker signature in Alzheimer's 
disease neuroimaging initiative subjects. Ann Neurol. 2009; 65(4):403–413. [PubMed: 19296504] 
Shaw LM, Vanderstichele H, Knapik-Czajka M, Figurski M, Coart E, Blennow K, Soares H, Simon 
AJ, Lewczuk P, Dean RA, Siemers E, Potter W, Lee VM, Trojanowski JQ, I. Alzheimer's Disease 
Neuroimaging. Qualification of the analytical and clinical performance of CSF biomarker analyses 
in ADNI. Acta Neuropathol. 2011; 121(5):597–609. [PubMed: 21311900] 
Horgusluoglu-Moloch et al. Page 14
Neurobiol Aging. Author manuscript; available in PMC 2018 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Spalding KL, Bergmann O, Alkass K, Bernard S, Salehpour M, Huttner HB, Bostrom E, Westerlund I, 
Vial C, Buchholz BA, Possnert G, Mash DC, Druid H, Frisen J. Dynamics of hippocampal 
neurogenesis in adult humans. Cell. 2013; 153(6):1219–1227. [PubMed: 23746839] 
Swaminathan S, Shen L, Risacher SL, Yoder KK, West JD, Kim S, Nho K, Foroud T, Inlow M, Potkin 
SG, Huentelman MJ, Craig DW, Jagust WJ, Koeppe RA, Mathis CA, Jack CR Jr, Weiner MW, 
Saykin AJ, I. Alzheimer's Disease Neuroimaging. Amyloid pathway-based candidate gene analysis 
of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Brain 
Imaging Behav. 2012; 6(1):1–15. [PubMed: 21901424] 
Tebano MT, Martire A, Rebola N, Pepponi R, Domenici MR, Gro MC, Schwarzschild MA, Chen JF, 
Cunha RA, Popoli P. Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-
localized and functionally interact in the hippocampus: a possible key mechanism in the 
modulation of N-methyl-D-aspartate effects. J Neurochem. 2005; 95(4):1188–1200. [PubMed: 
16271052] 
Urban N, Guillemot F. Neurogenesis in the embryonic and adult brain: same regulators, different roles. 
Front Cell Neurosci. 2014; 8:396. [PubMed: 25505873] 
Vaz SH, Lerias SR, Parreira S, Diogenes MJ, Sebastiao AM. Adenosine A2A receptor activation is 
determinant for BDNF actions upon GABA and glutamate release from rat hippocampal 
synaptosomes. Purinergic Signal. 2015; 11(4):607–612. [PubMed: 26452489] 
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, 
Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Shen L, Siuciak JA, Soares H, 
Toga AW, Trojanowski JQ, I. Alzheimer's Disease Neuroimaging. The Alzheimer's Disease 
Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 
2013; 9(5):e111–194. [PubMed: 23932184] 
Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association 
scans. Bioinformatics. 2010; 26(17):2190–2191. [PubMed: 20616382] 
Winner B, Winkler J. Adult neurogenesis in neurodegenerative diseases. Cold Spring Harb Perspect 
Biol. 2015; 7(4):a021287. [PubMed: 25833845] 
Yao B, Jin P. Unlocking epigenetic codes in neurogenesis. Genes Dev. 2014; 28(12):1253–1271. 
[PubMed: 24939932] 
Yee BK, Singer P, Chen JF, Feldon J, Boison D. Transgenic overexpression of adenosine kinase in 
brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs. Eur J 
Neurosci. 2007; 26(11):3237–3252. [PubMed: 18005073] 
Horgusluoglu-Moloch et al. Page 15
Neurobiol Aging. Author manuscript; available in PMC 2018 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Highlights
• Candidate pathways and genes which play a role in neurogenesis in the adult 
brain are manually-curated.
• ADORA2A is significantly associated with hippocampal volume
• A SNP (rs9608282) upstream of ADORA2A is associated with larger 
hippocampal volume and better memory performance.
• rs9608282 may have a protective effect on brain structure and function in 
neurogenesis-related brain regions.
• There is a significant interaction effect of NMDA-receptor antagonist use and 
the ADORA2A rs9608282-T on memory performance.
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Figure 1. Genes playing roles in stem cells proliferation, differentiation, migration, and survival 
to new neurons during adult neurogenesis process
Glial-like radial stem cells (light blue); progenitors (pink); neuroblasts (purple); immature 
neurons (green); mature neurons (blue).
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Figure 2. Venn diagram of Adult neurogenesis-related genes and AD-susceptibility genes
Manually curated neurogenesis and AD related gene. {(GoGene) ∪ (Mango) ∪ (Qiagen) ∪ 
(GSEA)} ∩ {Pubmed Mining} = 401. AD-susceptibility genes (N=680) from AlzGene 
database and large-scale GWAS results. Eighty-one common genes were identified 
associated with both neurogenesis and AD. ∪: Union; ∩: Intersection.
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Figure 3. APOE ε4 and rs9608282 (ADORA2A) appear to exhibit independent, but opposite effect 
on hippocampal volume
Baseline hippocampal volume (adjusted for age, gender, ICV, MRI field strength) ± standard 
errors are shown based on (a) rs9608282 in ADORA2A (A2aR) across genotype groups. 
Presence of at least one copy of the minor allele (T) of rs9608282 was significantly 
associated with increased hippocampal volume (p = 0.002). Baseline hippocampal volume is 
also shown by (b) the number of APOE ε4 allele copies. Presence of at least one copy of the 
ε4 allele was significantly associated with decreased hippocampal volume (p < 0.0001). (c) 
For participants having APOE ε4 allele copies, participants carrying minor allele of 
rs9608282 had larger hippocampal volume than those who did not carry minor allele of the 
ADORA2A rs9608282 (p = 0.001).
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Figure 4. ADORA2A rs9608282 is associated with larger hippocampal volume in amyloid-positive 
participants (classified by PET scan and/or CSF-amyloid beta level)
For statistical analysis, each participant was classified by their amyloid status (positive 
versus negative) at the baseline visit (determined by standard cutoffs on [18F]Florbetapir 
PET scan and/or CSF amyloid level). The effect of the T allele on hippocampal volume was 
present in both amyloid-negative (left column) and amyloid-positive (right column) 
participants. Upon statistical analysis, rs9608282 is significantly associated with 
hippocampal volume in amyloid-negative and even amyloid-positive participants (p = 0.027, 
p =0.015, respectively).
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Figure 5. ADORA2A rs9608282 is associated with larger hippocampal volume in Memantine non-
users (NMDA (−)) and poorer memory performance in Memantine users (NMDA (+))
For statistical analysis, cognitively impaired participants were classified as either a 
Memantine user (NMDA (+)) or a Memantine non-user (NMDA (−)). (A) The rs9608282 T 
allele was associated with a larger mean hippocampal volume in Memantine non-user 
participants (p < 0.001). (B) Participants carrying at least one copy of minor allele (T) of the 
ADORA2A rs9608282 variant and using a NMDA-receptor antagonist had poorer memory 
performance.
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Figure 6. Association of memory composite score with rs9608282 in ADORA2A across genotype
Baseline memory composite score (adjusted for age, gender and education) ± standard errors 
are displayed based on rs9608282 genotype. Individuals with a TT genotype at the 
rs9608282 variant showed a 5% increase in memory performance relative to those with a 
GG genotype.
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Figure 7. 
Association of CSF tau level with rs9608282 in ADORA2A across genotype. CSF total tau 
level (adjusted for age and gender)) ± standard errors are displayed based on rs9608282 
genotype. Individuals with a TT genotype at the rs9608282 variant showed significant 
decrease in CSF tau level relative to those with a GG genotype.
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Figure 8. ADORA2A expression profiles across the hippocampus region
The square dot indicates the tissue sample location for human brain. In each square, heat 
map color represents the z-score over a probe ranging from green (z-score of −3 and below) 
through black to red (z-score of +3 and above). Red squares represents overexpression of the 
ADORA2A in specific locations, most especially in CA1 and CA2.
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Table 2
81 genes of gene-based association results in the discovery sample for hippocampal volume using common 
variants (MAF ≥ 0.05) where empirical p-values were calculated using 20,000 permutations in PLINK
Gene Number
of SNPs
in gene
Number of
significant
SNPs
(p<0.05,
r2<0.5)
Empirical
gene-based
p-value
List of significant SNP
ADORA2A 55 1 5×10−5 rs9608282
APOE 85 5 5×10−5 rs429358|rs7259620|rs34095326|rs4803770|rs157580
TLR4 58 2 0.01499 rs11789302|rs10759930
BCHE 201 4 0.02797 rs2686409|rs1355538|rs12107166|rs6807910
CXCL10 42 1 0.04795 rs4256246
S100B 220 1 0.05994 rs118078026
CXCL12 306 4 0.06194 rs11238990|rs11238991|rs1144472|rs17659345
TET1 387 3 0.06593 rs113716271|rs12776586|rs12221107
BCL2 368 5 0.07493 rs9957149|rs28564323|rs7236090|rs6567334|rs11872403
PTGS2 52 2 0.08492 rs7547677|rs2206593
ACHE 51 2 0.08791 rs13245899|rs73714210
SORL1 233 2 0.09091 rs9665907|rs643010
SLC6A4 63 1 0.09191 rs16965628
GRIN2B 1054 5 0.0999 rs34870448|rs11612709|rs12582848|rs11611667|rs2300256
NGFR 86 5 0.0999 rs584589|rs11466150|rs2072444|rs535717|rs2537710
MEF2C 232 1 0.1019 rs1065861
CXCL1 39 1 0.1039 rs2968710
NR3C1 238 5 0.1209 rs4912912|rs17209237|rs10050756|rs7719514|rs12653301
DKK1 40 2 0.1249 rs11001581|rs7100461
GRN 37 1 0.1319 rs114641762
CHAT 189 5 0.1379 rs885834|rs11101179|rs1720367|rs4615945|rs74981858
CHRNB2 39 5 0.1499 rs9616|rs9427094|rs12072348|rs67860750|rs4845653
Syn3 1388 5 0.1718 rs2157188|rs9609643|rs2710348|rs180958069|rs5749521
CCL2 43 1 0.1758 rs111843487
IGF1 89 4 0.1888 rs1549593|rs10860862|rs12821878|rs80280982
VEGFA 59 3 0.1908 rs9381248|rs3025006|rs699946
NGF 135 2 0.1978 rs6537860|rs4320778
MIF 77 1 0.2008 rs738807
IL6 77 2 0.2338 rs2069840|rs62449498
CASP3 94 2 0.2378 rs4647634|rs2696059
MMP9 57 2 0.2537 rs73112805|rs3918253
PRNP 94 2 0.2747 rs6052766|rs67017873
SNCA 444 1 0.2927 rs187644542
Neurobiol Aging. Author manuscript; available in PMC 2018 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Horgusluoglu-Moloch et al. Page 27
Gene Number
of SNPs
in gene
Number of
significant
SNPs
(p<0.05,
r2<0.5)
Empirical
gene-based
p-value
List of significant SNP
CDK5 53 2 0.3147 rs4148853|rs34403003
IL1B 42 1 0.3147 rs3917381
ADAM10 232 1 0.3197 rs544282
NOS3 71 1 0.3197 rs12666075
NRG1 2784 5 0.3227 rs147179882|rs2466068|rs7829383|rs2347071|rs11998153
APBB1 119 1 0.3487 rs11040880
LRRK2 360 3 0.3526 rs189800607|rs10878411|rs11564173
OLIG2 123 2 0.3626 rs17632819|rs76708155
NOS1 559 5 0.3826 rs67313272|rs4767542|rs816284|rs12228022|rs10850829
HIF1A 82 1 0.4186 rs12891737
FGF1 221 5 0.4326 rs1808258|rs2070715|rs249925|rs10041541|rs13179022
TGFB1 131 1 0.5135 rs4803459
IGF1R 520 5 0.5325 rs11631965|rs4966039|rs3743254|rs7166348|rs2272037
FAS 175 1 0.5774 rs12767306
APP 554 5 0.6214 rs2829960|rs6516705|rs13046930|rs6516715|rs117104544
NTRK2 605 4 0.6264 rs17087710|rs28580203|rs1047896|rs1006446
DYRK1A 380 1 0.6593 rs28550863
ESR2 412 4 0.6983 rs1152576|rs4986938|rs10146107|rs12587140
RELN 1552 5 0.7932 rs2299373|rs3819491|rs39377|rs1476446|rs694894
ESR1 810 1 0.7972 rs55650062
ABCA2 61 0 1 NA
ADRA2A 27 0 1 NA
BDNF 122 0 1 NA
CAV1 129 0 1 NA
CDK5R1 24 0 1 NA
CHRNA7 2 0 1 NA
CNTF 29 0 1 NA
FOS 48 0 1 NA
GSK3B 329 0 1 NA
HTR2A 203 0 1 NA
NEUROD1 54 0 1 NA
NPY 131 0 1 NA
PLCG1 60 0 1 NA
PSEN1 154 0 1 NA
SIRT1 98 0 1 NA
THRA 82 0 1 NA
TNF 40 0 1 NA
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Gene Number
of SNPs
in gene
Number of
significant
SNPs
(p<0.05,
r2<0.5)
Empirical
gene-based
p-value
List of significant SNP
TNFR1A 4 0 1 NA
TNFR1B 54 0 1 NA
DLD 24 0 1 NA
GLP1R 98 0 1 NA
IFNG 19 0 1 NA
Plau 30 0 1 NA
PSEN2 19 0 1 NA
SOD2 5 0 1 NA
tp53 5 0 1 NA
CST3 92 0 1 NA
CHRM1 47 0 1 NA
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Table 3
Association of rs9608282 in ADORA2A with neuroimaging phenotypes and memory composite scores with 
and without diagnosis (DX) adjustment. SNP-based association results (p-values) in the discovery sample for 
hippocampal volume, neurogenesis-related hippocampal sub-regions, memory performance, and CSF total tau 
level.
rs9608282 p-value after adjusting for
DX
p-value without adjusting
for DX
Hippocampal Volume 3.29×10−4 1.14×10−5
Neurogenesis-Related Hippocampal Sub-regions 4.55×10−3 2.50×10−4
Memory Composite Score 2.18×10−1 7.45×10−3
CSF Total Tau 2×10−1 2.3×10−2
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Table 4
Meta-analysis of ADORA2A with hippocampal volume in three independent cohorts: ADNI, AddNeuroMed 
and IMAS.
ADNI
p-value
AddNeuroMed
p-value
IMAS
p-value
Meta-analysis
p-value
ADORA2A 5×10−5 2.1×10−1 2.95×10−1 4.3×10−5
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Table 5
Meta-analysis of rs9608282 with hippocampal volume in three independent cohorts: ADNI, AddNeuroMed 
and IMAS.
rs9608282 N Effect of rs9608282 (T)
(β value)
p-value
ADNI 1563 146.9 1.14×10−5
AddNeuroMed 218 362.4 2.34×10−2
IMAS 59 −263.2 4.59×10−2
Meta-analysis 1840 7.88×10−6
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